キッセイ薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/04 | 3,835 | 3,845 | 3,675 | 3,750 | -225 | -5.7% | 292,100 |
| 2025/02/03 | 3,950 | 3,980 | 3,930 | 3,975 | +15 | +0.4% | 111,200 |
| 2025/01/31 | 3,975 | 4,005 | 3,960 | 3,960 | -15 | -0.4% | 59,700 |
| 2025/01/30 | 3,960 | 3,995 | 3,960 | 3,975 | +10 | +0.3% | 102,000 |
| 2025/01/29 | 3,980 | 4,015 | 3,960 | 3,965 | -45 | -1.1% | 84,400 |
| 2025/01/28 | 4,020 | 4,075 | 3,975 | 4,010 | +5 | +0.1% | 76,600 |
| 2025/01/27 | 3,925 | 4,040 | 3,855 | 4,005 | +110 | +2.8% | 155,100 |
| 2025/01/24 | 3,885 | 3,915 | 3,840 | 3,895 | +30 | +0.8% | 71,200 |
| 2025/01/23 | 3,815 | 3,875 | 3,800 | 3,865 | +10 | +0.3% | 93,100 |
| 2025/01/22 | 3,885 | 3,890 | 3,850 | 3,855 | ±0 | ±0% | 59,200 |
| 2025/01/21 | 3,855 | 3,890 | 3,840 | 3,855 | +10 | +0.3% | 55,200 |
| 2025/01/20 | 3,900 | 3,925 | 3,835 | 3,845 | -15 | -0.4% | 64,000 |
| 2025/01/17 | 3,845 | 3,955 | 3,840 | 3,860 | +20 | +0.5% | 125,100 |
| 2025/01/16 | 3,900 | 3,975 | 3,840 | 3,840 | -40 | -1% | 136,200 |
| 2025/01/15 | 4,025 | 4,075 | 3,880 | 3,880 | -215 | -5.3% | 253,500 |
| 2025/01/14 | 4,060 | 4,110 | 4,005 | 4,095 | ±0 | ±0% | 109,000 |
| 2025/01/10 | 4,050 | 4,140 | 4,035 | 4,095 | -15 | -0.4% | 113,000 |
| 2025/01/09 | 4,110 | 4,230 | 4,090 | 4,110 | -30 | -0.7% | 148,800 |
| 2025/01/08 | 4,150 | 4,175 | 4,100 | 4,140 | -35 | -0.8% | 139,000 |
| 2025/01/07 | 4,200 | 4,270 | 4,175 | 4,175 | ±0 | ±0% | 127,900 |
| 2025/01/06 | 4,180 | 4,225 | 4,140 | 4,175 | +15 | +0.4% | 242,800 |
| 2024/12/30 | 4,170 | 4,185 | 4,120 | 4,160 | -10 | -0.2% | 162,200 |
| 2024/12/27 | 3,985 | 4,185 | 3,980 | 4,170 | +195 | +4.9% | 281,400 |
| 2024/12/26 | 3,990 | 4,035 | 3,920 | 3,975 | -25 | -0.6% | 227,900 |
| 2024/12/25 | 3,600 | 4,000 | 3,600 | 4,000 | +445 | +12.5% | 359,700 |
| 2024/12/24 | 3,520 | 3,555 | 3,515 | 3,555 | +35 | +1% | 44,700 |
| 2024/12/23 | 3,485 | 3,550 | 3,485 | 3,520 | +75 | +2.2% | 62,200 |
| 2024/12/20 | 3,530 | 3,535 | 3,445 | 3,445 | -65 | -1.9% | 90,100 |
| 2024/12/19 | 3,465 | 3,545 | 3,465 | 3,510 | ±0 | ±0% | 47,600 |
| 2024/12/18 | 3,525 | 3,530 | 3,480 | 3,510 | -10 | -0.3% | 53,300 |
| 2024/12/17 | 3,530 | 3,565 | 3,500 | 3,520 | -10 | -0.3% | 45,700 |
| 2024/12/16 | 3,545 | 3,555 | 3,510 | 3,530 | -15 | -0.4% | 42,600 |
| 2024/12/13 | 3,575 | 3,600 | 3,515 | 3,545 | -55 | -1.5% | 82,600 |
| 2024/12/12 | 3,605 | 3,625 | 3,570 | 3,600 | +25 | +0.7% | 70,800 |
| 2024/12/11 | 3,580 | 3,605 | 3,570 | 3,575 | +5 | +0.1% | 47,500 |
| 2024/12/10 | 3,600 | 3,605 | 3,565 | 3,570 | -5 | -0.1% | 47,400 |
| 2024/12/09 | 3,555 | 3,600 | 3,555 | 3,575 | +10 | +0.3% | 41,000 |
| 2024/12/06 | 3,610 | 3,625 | 3,550 | 3,565 | -45 | -1.2% | 54,600 |
| 2024/12/05 | 3,675 | 3,680 | 3,610 | 3,610 | -65 | -1.8% | 50,500 |
| 2024/12/04 | 3,700 | 3,715 | 3,660 | 3,675 | -50 | -1.3% | 48,900 |
| 2024/12/03 | 3,675 | 3,760 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
| 2024/12/02 | 3,635 | 3,730 | 3,635 | 3,700 | +55 | +1.5% | 81,900 |
| 2024/11/29 | 3,640 | 3,670 | 3,605 | 3,645 | +35 | +1% | 45,900 |
| 2024/11/28 | 3,590 | 3,630 | 3,545 | 3,610 | -20 | -0.6% | 58,400 |
| 2024/11/27 | 3,670 | 3,670 | 3,580 | 3,630 | -55 | -1.5% | 48,700 |
| 2024/11/26 | 3,655 | 3,685 | 3,620 | 3,685 | +85 | +2.4% | 54,500 |
| 2024/11/25 | 3,695 | 3,725 | 3,545 | 3,600 | -55 | -1.5% | 167,700 |
| 2024/11/22 | 3,680 | 3,725 | 3,625 | 3,655 | -35 | -0.9% | 48,300 |
| 2024/11/21 | 3,700 | 3,730 | 3,670 | 3,690 | -15 | -0.4% | 36,900 |
| 2024/11/20 | 3,625 | 3,705 | 3,625 | 3,705 | +80 | +2.2% | 45,700 |
151～
200
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
